Although prostate-specific antigen (PSA) is a routine diagnostic marker for PCa, its sensitivity is compromised by false positive results, which might lead to overtreatment of indolent disease [3] and mislead treatment decisions at relapse [4]. Here, KLK3 is linked to posterior cortical atrophy.